Fadi Haddad

Statistics

Publications

Citations

605

H-Index

Active since

2013

Affiliations

University of California San Diego(Current)

Sharp Memorial Hospital

Sharp Grossmont Hospital

Sharp Rees-Stealy Medical Group

University of Wisconsin–Madison

Fadi Haddad is an author at University of California San Diego specializing in infectious diseases, pharmacotherapy, and antimicrobial pharmacotherapy.

Publications per year

2013–2023

Publications

Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

Matthew Geriak, Fadi Haddad, Khulood Rizvi et al. · Antimicrobial Agents and Chemotherapy · 2019 · 193 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments

Erin K McCreary, Ravina Kullar, Matthew Geriak et al. · Open Forum Infectious Diseases · 2019 · 90 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Treatment of High-Level Gentamicin-Resistant Enterococcus faecalis Endocarditis with Daptomycin plus Ceftaroline

George Sakoulas, Poochit Nonejuie, Victor Nizet et al. · Antimicrobial Agents and Chemotherapy · 2013 · 65 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia

Erlinda R. Ulloa, Kavindra V. Singh, Matthew Geriak et al. · Clinical Infectious Diseases · 2019 · 54 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019

George Sakoulas, Matthew Geriak, Ravina Kullar et al. · Critical Care Explorations · 2020 · 50 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

1–5 of 10